Endoscopic nasobiliary drainage: an effective treatment option for benign recurrent intrahepatic cholestasis (BRIC).
Ashok Kumar ChoudhuryAnand V KulkarniBishnupriya SahooChhagan BihariPublished in: BMJ case reports (2017)
Benign recurrent intrahepatic cholestasis (BRIC) is characterised by recurrent episodes of jaundice, severe pruritus and low or normal serum γ-glutamyltransferase activity lasting from several weeks to months. BRIC is an autosomal recessive disorder caused by the mutation in either of the two hepatic transporter genes-ATP8B1 or ABCB11 gene. The disease is very well known for episodic flare of jaundice with cholestatic symptoms that are spontaneous or perpetuated by acute insults, followed by self-recovery. There is no proven medical therapy and rarely does it progress to progressive familial intrahepatic cholestasis (PFIC) or biliary cirrhosis. BRIC may be associated with nephrolithiasis, diabetes or pancreatitis. Here, we report a case of BRIC with spontaneous flare and further complicated by drug-induced liver injury with disabling cholestastic symptoms, who underwent endoscopic nasobiliary drainage and was completely relieved of the distressing symptoms.
Keyphrases
- drug induced
- liver injury
- ultrasound guided
- genome wide
- sleep quality
- type diabetes
- early onset
- cardiovascular disease
- multiple sclerosis
- healthcare
- genome wide identification
- copy number
- liver failure
- emergency department
- glycemic control
- adverse drug
- metabolic syndrome
- respiratory failure
- mesenchymal stem cells
- bone marrow
- preterm birth
- intensive care unit
- aortic dissection
- combination therapy
- gestational age
- weight loss
- extracorporeal membrane oxygenation
- mechanical ventilation